Anne Hultquist

2.4k citations
13 papers · 1.4k · 1 hit paper · h-index 10

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune cells in cancer

Papers in

    • Acute Myeloid Leukemia Research 7
    • Hematopoietic Stem Cell Transplantation 2
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Anne Hultquist

12 papers receiving 1.4k citations

Anne Hultquist's Hit Papers

Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential 2005 · 884 citations
8840+7+14Years since publication250500750

Peers

Anne Hultquist
Comparison fields: 5 of 67
  • Hematology 700
  • Immunology 718
  • Genetics 160
  • Molecular Biology 589
  • Cell Biology 105
Replace Karina Liuba with:
Karina Liuba Sweden
Christina T. Jensen Sweden
Jun Ooehara Japan
Lina Thorén Sweden
Matthew P. McCormack Australia
Ole Johan Borge Sweden
Judith Schütte United Kingdom
Deidre Daria United States
Alexis Dumortier Switzerland
Nari Harakawa Japan
Anne Hultquist relative to Karina Liuba Sweden Karina Liuba's profile →
Citations per field
00.5×1.5×
Karina Liuba · 1×
Citations per year

Countries citing papers authored by Anne Hultquist

Since Specialization
Citations

This map shows the geographic impact of Anne Hultquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Hultquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Hultquist more than expected).

Fields of papers citing papers by Anne Hultquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Hultquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Hultquist. The network helps show where Anne Hultquist may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Hultquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Hultquist Line = papers co-authored together Anne Hultquist links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential
Hit paper breakdown →
2005884
2 2007271
3 201154
4 201033
5 200125
6 200723
7 200922
8 201122
9 201519
10 201813
11 20048
12 20232
13 20250

About Anne Hultquist

Anne Hultquist is a scholar working on Hematology, Genetics, Molecular Biology, Neurology and Immunology, having authored 13 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (3 papers), Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Hematology (700 citations), Immunology (718 citations), Genetics (160 citations), Molecular Biology (589 citations) and Cell Biology (105 citations). Anne Hultquist has collaborated with scholars based in Sweden, United Kingdom and Russia. Frequent co-authors include Sten Eirik W. Jacobsen, Natalija Buza-Vidas, Lina Thorén, Mikael Sigvardsson, Liping Yang, Robert Månsson, Karina Liuba, Kristina Anderson, Jörgen Adolfsson and Ewa Sitnicka. Their work appears in journals such as Blood, Cytometry Part A, Molecular Cancer Therapeutics, Molecular Cancer Research and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact